References in periodicals archive ?
2008; MELO & MOURAO, 2008), we performed an inhibition factor IIa by AT assay in the presence of the [SP.
In contrast, the result obtained by the inactivation of factor IIa by AT assay reported here do not agrees with other descriptions for eight different SPs isolated from Caulerpa spp.
With high dose heparin Factor IIa may also be inactivated.
The Competitive Intelligence Report Antithrombotics as of May 2007 provides a competitor analysis in the development pipeline of novel anticoagulant and antiplatelet agents directed against targets such as factor IIa (thrombin), factor Xa, the ADP platelet receptor and PAR-1 /thrombin receptor and other novel targets.
Anticoagulants Anti-thrombin III Agonists: Heparin, Low Molecular Weight Heparin, ATIII Inhibitors of Factor IIa (Thrombin) Inhibitors of Factor Xa Dual Inhibitors of Factor IIa and Xa Inhibitors of Factor IXa Inhbitors of Factor VII/Tissue Factor Inhibitors of Factor VIII Antiplatelet Agents Inhibitors of Platelet ADP Receptor Inhibitors of PAR-1 / Thrombin Receptor Antagonists of GPIIb/IIIa Antagonists of GPIb & von Willebrand Factor Antagonists of GPVI Antithrombotics